Infiniti Labs, INC

Infiniti Labs, INC was paid $2.53M by Medicaid between Jan 2018 and Dec 2024, across 44 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 33% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#25 of 225

Median peer was paid$74K

This provider vs. median34×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	161,336	$883K
2019	186,370	$565K
2020	95,425	$381K
2021	49,574	$271K
2022	36,926	$247K
2023	26,645	$144K
2024incomplete	6,471	$40K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	33%	28,181	20,030	$826K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	26%	20,280	17,200	$662K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	8.2%	20,341	15,313	$207K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	7.2%	5,172	4,913	$183K
80325		1.8%	12,885	9,970	$45K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.5%	1,259	1,126	$38K
80365		1.4%	34,497	14,615	$36K
80333		1.2%	12,012	9,251	$30K
80351		1.1%	1,929	1,237	$29K
80346		1.1%	17,005	13,401	$28K
80356		1.0%	17,852	14,222	$26K
80354		<1%	19,998	13,362	$24K

32 more codes

80368		<1%	21,503	$24K
80361		<1%	18,294	$24K
80336		<1%	12,976	$23K
80348		<1%	18,309	$21K
80359		<1%	17,847	$20K
80338		<1%	15,819	$19K
80349		<1%	16,581	$19K
80373		<1%	16,772	$19K
80372		<1%	16,696	$19K
80360		<1%	15,990	$19K
83992		<1%	17,169	$18K
80366		<1%	14,703	$17K
80370		<1%	14,497	$17K
80355		<1%	14,486	$17K
80364		<1%	9,712	$16K
80357		<1%	11,017	$16K
80353		<1%	17,871	$15K
80342		<1%	9,558	$14K
80358		<1%	17,243	$13K
80367		<1%	13,740	$12K
80324		<1%	7,619	$10K
84311		<1%	19,070	$7K
80362		<1%	8,407	$5K
80344		<1%	2,550	$3K
80321		<1%	1,433	$2K
80371		<1%	3,494	$2K
80339		<1%	2,574	$1K
80369		<1%	471	$1K
80323		<1%	2,579	$958.37
80363		<1%	3,187	$753.47
82570		<1%	9,142	$520.09
80343		<1%	27	$139.50

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNELSON, GREG (PRESIDENT)

Same official

Other billing entities under NELSON, GREG

Full network →

Provider	Location	Paid
Apex Labs, INC	Tampa, FL	$1.58M
Nelson-Nam a Medical Corporation	Van Nuys, CA	$86K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.